The newsletter from the central resource for the Swiss biotech industry
May 2026
After the Swiss Biotech Day is before the next
Save the date: April 26-27, 2027
Our flagship event, the Swiss Biotech Day, reached new heights this year, welcoming more than 3,500 participants from around the world. The event continues to grow in scale and international reach, reinforcing its position as a premier global biotech conference.
Save the date for next year and join the international biotech community for another inspiring edition.
The Swiss Biotech Report 2026
Talent and tenacity
Launched at the Swiss Biotech Day, the report provides insights into how Switzerland’s biotech sector performed in 2025 and how it continues to demonstrate strength and momentum in a challenging global financing environment. This year’s focus is on “talent and tenacity”: Switzerland’s ability to develop, attract, and retain talent, and to translate it into trusted international partnerships that advance healthcare innovation worldwide. Read the Swiss Biotech Report
Swiss Biotech Association strengthens leadership
Matthias Fehr joins board
Matthias Fehr, Head of Private Equity at HBM Partners, was elected as a new board member of the Swiss Biotech Association at our general assembly on May 4 at the Swiss Biotech Day. See the Swiss Biotech Association board & management team and take a look at our 2025 annual report for more insights on how we support the Swiss biotech industry.
Swiss Biotech Directory in print and online
Find the right partner fast
The Swiss Biotech Directory is the most comprehensive compendium of Swiss biotech companies and is now available in print. An always updated digital version is also available, making it easy to identify and connect with the right partners across the Swiss biotech ecosystem.
Patrick Aebischer receives Swiss Biotech Success Stories Award
To recognize outstanding achievements, the 2026 Swiss Biotech Success Stories Award was presented to Patrick Aebischer, a leading neuroscientist and prominent Swiss biotech leader whose career spans across research, institutional leadership and entrepreneurship. During his presidency from 2000 to 2016, he transformed EPFL into a leading global research institute. He founded four biotech companies: CytoTherapeutics, Modex, Amazentis (Timeline) and Vandria. Currently, he is on the boards of Nestlé and PolyPeptide, and previously served as a board member of Lonza and Logitech. He is also managing partner at Limani Partners, and was senior partner at ND Capital and chairman of the Novartis Venture Fund.
Advertisement
New formats connect biotech leaders across disciplines
Swiss biotech peer-to-peer meetings expand across biotech roles
In 2026, we expand the already successfully established peer-to-peer formats for biotech CEOs, CFOs, and HR leaders with informal meetings for chief scientific and medical officers (Swiss biotech CSO meeting), and chemistry, manufacturing, and quality control specialists (Swiss biotech CMC meeting). These platforms enable the exchange of best practices, discussion of R&D trends, and addressing key challenges across management, talent, development, manufacturing, and financing. Here are the dates at a glance - Register early to secure your spot.
The second edition of Bayer Co.Lab Connect Basel supports early-stage entrepreneurs in Switzerland. As part of Bayer’s global incubator network, the initiative connects startups with expertise, resources, and partners across key innovation hubs. The program helps Swiss startups scale internationally while remaining locally based. More info & apply
Order your spot now
Join Swiss Biotech Pavilions at coming up biotech conferences
Use the Swiss Biotech Pavilion as your home base for your activities. The official Swiss presence is organized by Switzerland Global Enterprise in collaboration with the Swiss Biotech Association. As Swiss Biotech Association member you benefit from discounts.
As a startup with global ambitions you might qualify for funding and participate in international trade fairs as exhibitor. Learn more and apply for a grant.
Exploring practical approaches to circular economy in life sciences, with regulatory insights, case studies and a focus on implementation and collaboration.
The Swiss Biotech Association partners with several organizations to provide a perfect mix of education and long-term professional development with discount for our members.
Introduces all elements of the supply chain for medicines and other health commodities, including selection, procurement, distribution and use.
May 28
Café and croissant: FONGIT life sciences Get an update of the Geneva startup community, meet with entrepreneurs, and expand your professional network over coffee and croissants.
A practical workshop on eu market access and reimbursement for medical devices, helping you understand key fundamentals.
Jun 4
Good clinical practice refresher A refresher training in accordance with Swissethics, summarizing the most important elements of the ICH E6(R3) GCP guideline for the conduct of clinical research.
A site visit exploring how green chemistry is implemented in pharmaceutical manufacturing, with insights into innovation, collaboration and scalable solutions.
Engage in open, science-driven discussions focused on the future of bioprocessing. Get to know tools redefining process development, monitoring, and control.
You are receiving this email because you were in contact with us or have subscribed to our newsletter. You can unsubscribe any time, but be aware that you will not receive any more info from us.
